Balwani Shut Down $96M Investor's Due Diligence, Jury Told
A hedge fund manager testified Wednesday in the fraud trial of former Theranos executive Ramesh "Sunny" Balwani that before his firm and its affiliates invested $96.1 million he tried to do...To view the full article, register now.
Already a subscriber? Click here to view full article